Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis

EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC

(2019) Yalei Yin et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The roles of glucose metabolic reprogramming in chemo- and radio-resistance

(2019) Jinguan Lin et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1

(2018) Hongsheng Wang et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas

(2018) Carlo Lucchesi et al.   JAMA Oncology

Comprehensive Characterization of Cancer Driver Genes and Mutations

(2018) Matthew H. Bailey et al.   CELL

Lactate: A Metabolic Driver in the Tumour Landscape

(2018) Luigi Ippolito et al.   TRENDS IN BIOCHEMICAL SCIENCES

Prognostic value of ERBB4 expression in patients with triple negative breast cancer

(2016) Ji-Yeon Kim et al.   BMC CANCER

Mitochondria and Cancer

(2016) Wei-Xing Zong et al.   MOLECULAR CELL

MYC, Metabolism, and Cancer

(2015) Z. E. Stine et al.   Cancer Discovery

High Incidence of ErbB3, ErbB4, and MET Expression in Ovarian Cancer

(2014) Suzy Davies et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Exploiting the bad eating habits of Ras-driven cancers

(2013) E. White   GENES & DEVELOPMENT

The ErbB/HER family of protein-tyrosine kinases and cancer

(2013) Robert Roskoski   PHARMACOLOGICAL RESEARCH

Slow down to stay alive

(2012) Yingqi Hua et al.   CANCER

Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation

(2012) M. Jain et al.   SCIENCE

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Function ofERBB4is determined by alternative splicing

(2011) Ville Veikkolainen et al.   CELL CYCLE

Rewiring of glycolysis in cancer cell metabolism

(2010) Jason W. Locasale et al.   CELL CYCLE

Cell Death or Survival Promoted by Alternative Isoforms of ErbB4

(2010) Maria Sundvall et al.   MOLECULAR BIOLOGY OF THE CELL

MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities

(2009) C. V. Dang et al.   CLINICAL CANCER RESEARCH

Potential of ErbB4 antibodies for cancer therapy

(2009) Maija Hollmén et al.   Future Oncology

Tumor suppressors and cell metabolism: a recipe for cancer growth

(2009) R. G. Jones et al.   GENES & DEVELOPMENT

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

(2009) Ping Gao et al.   NATURE

Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4

(2009) Todd D Prickett et al.   NATURE GENETICS

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE

The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation

(2008) Ralph J. DeBerardinis et al.   Cell Metabolism

Roles of p53, Myc and HIF-1 in Regulating Glycolysis — the Seventh Hallmark of Cancer

(2008) S. J. Yeung et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

HER4 Intracellular Domain (4ICD) Activity in the Developing Mammary Gland and Breast Cancer

(2008) Frank E. Jones   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Role of ErbB4 in Breast Cancer

(2008) Maria Sundvall et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Mitochondrial DNA Content: Its Genetic Heritability and Association With Renal Cell Carcinoma

(2008) J. Xing et al.   JNCI-Journal of the National Cancer Institute

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

(2008) D. R. Wise et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA